567 participants
Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-11-12
- Start Date:
- 2015-11-11
- Completion:
- 2017-05-09
Conditions
- HIV-1 Infection
Interventions
- DRUG